Thursday , May 25 2017
Home / General Health / Zofran

Zofran

Zofran Online Generic

Zofran blocks the actions of chemicals in the body that can trigger nausea and vomiting.
Zofran is used to prevent nausea and vomiting that may be caused by surgery or by medicine to treat cancer (chemotherapy or radiation).
Zofran is not for preventing nausea or vomiting that is caused by factors other than cancer treatment or surgery.
Zofran generic has been approved by FDA.

Zofran and Pregnancy

There is some evidence that suggests Zofran may not be safe to take during pregnancy because of the risk of birth defects.
Some research has linked the use of Zofran during pregnancy to cleft palates, according to a 2012 report in the journal Canadian Family Physician.
Additionally, Zofran was never approved to treat nausea and vomiting from morning sickness in pregnant women.
Despite that fact, in 2012 GlaxoSmithKline pleaded guilty to illegally promoting the use of Zofran to prevent morning sickness (among other charges), and paid a $3 billion fine.
A number of lawsuits have been filed against GlaxoSmithKline over the safety of Zofran.
Research is continuing into the risk of birth defects when Zofran is taken by pregnant women. According to the Zofran prescribing information, “this drug should be used during pregnancy only if clearly needed.”
Though Zofran has been detected in the breast milk of laboratory animals, experts don’t know whether Zofran passes into human breast milk.
Because of these risks, be sure to tell your doctor if you are pregnant or breastfeeding before taking Zofran. Also, tell your doctor if you become pregnant or are considering breastfeeding while taking Zofran.

Zofran Side Effects

The most common side effects are:
Headache
Fatigue
Constipation
Diarrhea
Dizziness
Rash
Hiccups
Flushing
Serious side effects can occur. If you have any of these side effects, call your doctor right away:
Temporary blurred vision or loss of vision
Severe rash, hives, or a rash that causes blisters and peeling
Yellowing of skin or eyes or dark-colored urine
Seizure
Chest pain
Loss of consciousness
Swelling of face, lips, tongue, or other parts of the body
Difficulty breathing, swallowing, or talking

Zofran Dosage

Your dose of Zofran will depend on the condition you have. Zofran comes in 4- and 8-milligram (mg) tablets.
Zofran 4 mg taken 30 minutes before starting cancer treatment. The 4-mg dose is taken
Zofran ODT comes in 4- and 8-mg orally disintegrating tablets. Zofran also comes in liquid form.
Zofran ODT orally disintegrating tablets are a serotonin 5-HT3 receptor blocker. It works by blocking a chemical thought to be a cause of nausea and vomiting in certain situations (eg, chemotherapy).
To treat or prevent nausea or vomiting, you’ll usually take a tablet 30 minutes before chemotherapy, one or two hours before radiation therapy, and one hour before surgery.
You may need additional doses up to three times a day during treatment or for a few days after treatment of cancer.
For chemotherapy, a typical adult dose of Zofran can range from 16 to 24 mg daily.
For radiation therapy, a typical adult dose of Zofran is 24 mg daily.
For prevention of nausea and vomiting after surgery, a typical adult dose of Zofran is 16 mg before surgery.

Zofran Overdose

It is possible to take an overdose of Zofran. Overdose symptoms can occur if you take 10 times the normal daily dose.
Symptoms of an overdose of Zofran may include:
Sudden and temporary blindness
Severe constipation
Fainting
Irregular heartbeat

Missed Dose of Zofran

You should only take Zofran exactly as directed by your doctor.
To take Zofran ODT correctly, make sure to carefully peel open the package. Do not push the pill through the foil. Make sure your hands are dry and put the tablet on your tongue immediately.
If you miss a dose of Zofran, take the missed dose as soon as you remember.
If it’s almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose.

 


 

More Articles you can read:

Leave a Reply

Your email address will not be published. Required fields are marked *


*